ADAG

Adagene Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Powered by its proprietary Dynamic Precision Library (DPL) platform, composed of NEObody™, SAFEbody®, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Current Price

—

Profile

Valuation (TTM)

Market Cap—

P/E—

EV—

P/B—

Shares Out—

P/Sales—

Revenue—

EV/EBITDA—

Adagene Inc (ADAG) Stock News

ADAG Latest News

ADAG Stock News & Headlines

Latest stock news and headlines for Adagene Inc (ADAG). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.

Sector: Healthcare. Industry: Biotechnology. This page aggregates the latest news articles relevant to ADAG from financial news sources, helping investors stay current on events that may impact Adagene Inc's stock price.

News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Adagene Inc (ADAG).